About Kellan
Kellan Weston completed her PhD in Molecular and Cellular Biology at Washington University in
St. Louis. There, she studied genetic gain of function variants in UBE3A, the causative gene for
Angelman Syndrome, a rare neurodevelopmental disorder. While at Washington University, she
also worked for several scientific communication organizations, including writing for the Dept. of
Neuroscience website, acting as managing editor for the InPrint editing team, and analyzing
research data for the WashU Bioethics Research Center.
Now, she is a postdoctoral fellow in translational neuroscience at COMBINEDBrain, a nonprofit
research organization dedicated to jumpstarting research for rare neurodevelopmental
disorders. Kellan acts as chief scientific officer for several patient advocacy groups, leads
working groups focused on dug repurposing, and creates strategic research plans.
Kellan is the sister of a person diagnosed with PCDH19 syndrome and is driven by her deep
personal interest in helping patients with PCDH19 and similar rare genetic disorders.